Skip to content

Clinical Evaluation of Cervical Ripening in the Outpatient Setting

Clinical Evaluation of Cervical Ripening in the Outpatient Setting Using Mifepristone Versus Balloon Catheter: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04271722
Enrollment
101
Registered
2020-02-17
Start date
2020-01-15
Completion date
2022-12-30
Last updated
2024-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor; Forced or Induced, Affecting Fetus or Newborn, Labor Onset and Length Abnormalities

Keywords

cervical ripening, mifepristone, balloon catheter

Brief summary

A randomized controlled trial of mifepristone 200mg vs balloon catheter for cervical ripening.

Detailed description

Artificial induction of labour is currently required in 25-30% of all pregnancies, in high-resource countries. While the pharmacological modifications to the collagen matrix of the cervix, that allow it to dilate (cervical ripening) occur spontaneously in many women, allowing labour to be induced with oxytocin, in others the process needs to be triggered artificially. Cervical ripening is traditionally accomplished with prostaglandins or mechanical agents, in processes that typically require 12-24 hours of hospital stay. More recently, a limited number of hospitals have shifted towards starting the process in house, but then allowing women to return home and be re-evaluated on the following day. The main aims this study is to compare efficacy and patient satisfaction of mifepristone vs balloon catheter for cervical ripening.

Interventions

OTHERCervical ripening

Subjects will undergo cervical ripening in the outpatient setting. The patients will then be scheduled to return the next morning for induction of labor.

Sponsors

Centro Hospitalar Lisboa Norte
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant woman scheduled for induction of labor. * Age between 18 and 45 years. * Understanding and capable to sign informed consent. * Singleton pregnancy. * Gestational age ≥ 37 0/7 weeks. * Live fetus in cephalic presentation. * Intact membranes * Bishop score \< 6 * Estimated fetal weight \< 4500g * Without contraindication to vaginal delivery * No major fetal anomaly

Exclusion criteria

* Previous cesarean section or myomectomy * Hypertension * Diabetes * Thyroid disease * Maternal conditions with high risk of placental insufficiency

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with Bishop score ≥6 or spontaneous labour24 hoursProportion of patients (%) with Bishop score ≥6 or spontaneous labour 24 hours after intervention

Secondary

MeasureTime frameDescription
Mean of gain in Bishop score24 hoursMean of gain in Bishop score from intervention to hospital admission
Vaginal delivery within 48hrs1-2daysRate of vaginal deliveries within 48 hours since admission to hospital (%)
Pharmacological agents for labor induction (Prostaglandins, Oxytocin)1-2daysRate of women that required pharmacological cervical ripening agents (%) requirement (%)
Reduced fetal movements24 hoursRate of women who had reduced fetal movements during cervical ripening process (%)
Non reassuring fetal status24 hoursRate of women who had non reassuring fetal status(CTG) during cervical ripening process (%)
Patient Satisfaction: questionnaire1-4daysPatient satisfaction associated with intervention used for cervical ripening from patient questionnaire
Operative deliveries1-4daysProportion of patients that delivered vaginal by forceps assistance or vacuum (%) assistance.
Cesarean deliveries1-4daysProportion of patients that delivered by cesarean (%).
Analgesia requirement24 hoursRate of women who require any analgesia during cervical ripening process (%)
Vaginal bleeding24 hoursRate of women who had vaginal bleeding during cervical ripening process (%)
Time frame between intervention and active phase of labour1-2 daysTime frame between intervention and active phase of labour (min)
Time of Vaginal Delivery2-4daysDelivery time frame in mins from intervention
Number of Participants with vaginal delivery within 24hrs1-2daysRate of vaginal deliveries within 24 hours since admission to hospital (%)

Other

MeasureTime frameDescription
5 minute apgar score <71-4 daysRate of newborns with 5 minute apgar score \<7 (%)
Metabolic acidosis(pH< 7.00 e BD > 12 mmol/l)1-4 daysRate of metabolic acidosis (pH\< 7.00 e BD \> 12 mmol/l) (%)
Neonatal mortality1-7daysRate of neonatal mortality (%)
Neonatal Intensive Care Unit admission1-30 daysRate of newborns admitted in Neonatal Intensive Care Unit (%)
Postpartum haemorrhage1-7 daysRate of women with postpartum haemorrhage (%)

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026